{"id":"https://openalex.org/W3132286148","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps3-03","title":"Abstract PS3-03: [89Zr]-pertuzumab pet imaging reveals paclitaxel treatment efficacy is positively correlated with her2 expression in human breast cancer xenograft mouse models","display_name":"Abstract PS3-03: [89Zr]-pertuzumab pet imaging reveals paclitaxel treatment efficacy is positively correlated with her2 expression in human breast cancer xenograft mouse models","publication_year":2021,"publication_date":"2021-02-15","ids":{"openalex":"https://openalex.org/W3132286148","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps3-03","mag":"3132286148"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs20-ps3-03","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps3-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps3-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012929210","display_name":"Yun Lu","orcid":"https://orcid.org/0000-0001-9332-6832","observed_orcids":["https://orcid.org/0000-0001-9332-6832"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun Lu","raw_affiliation_strings":["University of Alabama at Birmingham, Birmgingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmgingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003986132","display_name":"Adriana V. F. Massicano","orcid":"https://orcid.org/0000-0002-6666-1317","observed_orcids":["https://orcid.org/0000-0002-6666-1317"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adriana Massicano","raw_affiliation_strings":["University of Alabama at Birmingham, Birmgingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmgingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002504233","display_name":"Patrick N. Song","orcid":"https://orcid.org/0000-0002-1545-0886","observed_orcids":["https://orcid.org/0000-0002-1545-0886"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Song","raw_affiliation_strings":["University of Alabama at Birmingham, Birmgingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmgingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100457373","display_name":"Meng Li","orcid":"https://orcid.org/0000-0001-5565-8799","observed_orcids":["https://orcid.org/0000-0001-5565-8799"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meng Li","raw_affiliation_strings":["University of Alabama at Birmingham, Birmgingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmgingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075304112","display_name":"Suzanne E. Lapi","orcid":"https://orcid.org/0000-0003-0090-0191","observed_orcids":["https://orcid.org/0000-0003-0090-0191"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne Lapi","raw_affiliation_strings":["University of Alabama at Birmingham, Birmgingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmgingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027284323","display_name":"Anna G. Sorace","orcid":"https://orcid.org/0000-0002-3640-3966","observed_orcids":["https://orcid.org/0000-0002-3640-3966"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Sorace","raw_affiliation_strings":["University of Alabama at Birmingham, Birmgingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmgingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"4_Supplement","first_page":"PS3","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7509999871253967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7509999871253967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.07699999958276749,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.06239999830722809,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ab","display_name":"ab","score":0.6179999709129333},{"id":"https://openalex.org/keywords/her2-expression","display_name":"HER2 expression","score":0.699999988079071},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9649999737739563},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9139999747276306},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6150000095367432},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.42100000381469727},{"id":"https://openalex.org/keywords/18f-fdg-pet-ct","display_name":"18F-FDG PET/CT","score":0.8629999756813049},{"id":"https://openalex.org/keywords/tumor-glucose-metabolism","display_name":"tumor glucose metabolism","score":0.9760000109672546},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.5960000157356262},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6340000033378601},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.6499999761581421},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.8629999756813049},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.4909999966621399},{"id":"https://openalex.org/keywords/radiolabeled-antibody-imaging","display_name":"radiolabeled antibody imaging","score":0.47099998593330383},{"id":"https://openalex.org/keywords/cleaved-caspase-3","display_name":"cleaved caspase-3","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.892206072807312},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7563482522964478},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.710096538066864},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6895602345466614},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6737306118011475},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6018177270889282},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.5844277143478394},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5141528248786926},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.406167596578598},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39718398451805115},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3832945227622986},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.37716221809387207},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3719581365585327},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3529125452041626},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12874844670295715},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs20-ps3-03","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps3-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps3-03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3136881925","https://openalex.org/W3083090129","https://openalex.org/W2318975154","https://openalex.org/W4283579441","https://openalex.org/W2789813750","https://openalex.org/W2914710001","https://openalex.org/W2314610986","https://openalex.org/W2128590097","https://openalex.org/W2391980969","https://openalex.org/W7219322403"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Paclitaxel":[2],"(PTX)":[3],"is":[4,21,28,49,113,359,441],"one":[5,193],"of":[6,16,34,41,81,104,124,198,240,285,390,457],"the":[7,14,32,77,102,152,163,328,387,458],"most":[8],"commonly":[9],"used":[10,268,278],"first-line":[11],"chemotherapies":[12],"in":[13,51,119,162,366,380,447],"treatment":[15,33,117,199,357,392,439],"breast":[17,36,52,126,368,449],"cancer.":[18,37,127],"However,":[19,330],"it":[20],"reported":[22],"that":[23,44,57],"overall":[24],"PTX":[25,116,205],"response":[26,48],"rate":[27],"between":[29],"30-60%":[30],"for":[31,46,253],"metastatic":[35],"Thus,":[38],"novel":[39],"discoveries":[40],"molecular":[42],"mechanisms":[43],"account":[45],"ineffective":[47],"critical":[50],"cancer":[53,369,450],"treatment.":[54,329],"[89Zr]-Pertuzumab":[55,189,283,372],"(antibody":[56],"targets":[58],"HER2":[59,82,110,183,363,377],"receptors)":[60],"and":[61,79,84,93,174,200,215,231,237,257,260,275,300,382,401,416],"2-deoxy-2-":[62],"[fluorine-18]":[63],"fluoro-D-glucose":[64],"([18F]-FDG)":[65],"positron":[66],"emission":[67],"tomography/computed":[68],"tomography":[69],"(PET/CT)":[70],"imaging":[71,191,226,374,385,436],"allows":[72],"us":[73],"to":[74,196,269,339],"noninvasively":[75],"measure":[76],"amount":[78],"heterogeneity":[80],"expression":[83,111,184,364,378,446],"tumor":[85,98,153,219,271,317],"glucose":[86],"metabolism.":[87],"These":[88],"methods":[89],"are":[90],"clinical":[91,404],"translatable":[92],"can":[94],"provide":[95],"insight":[96],"into":[97,141],"biology":[99],"changes":[100,326,335],"during":[101,327],"course":[103],"therapy.":[105],"This":[106,394],"study":[107],"evaluates":[108],"whether":[109],"level":[112,185,365,379],"correlated":[114,315,344,361,443],"with":[115,169,202,298,308,316,345,362,444],"efficacy":[118,358,440],"controlled":[120],"pre-clinical":[121],"mouse":[122,370,452],"models":[123,453],"HER2+":[125],"Experimental":[128],"Design:":[129],"BT474":[130,286],"(1\u00d7107),":[131],"MDA-MB-361":[132,291],"(6\u00d7106),":[133],"or":[134],"MDA-MB-231":[135,301],"(2\u00d7106)":[136],"cells":[137],"were":[138,160,245,248,267,277,289,294,304],"subcutaneously":[139],"injected":[140],"athymic":[142],"nude":[143],"mice":[144,159],"(N":[145],"=":[146],"7":[147],"per":[148],"cell":[149],"line).":[150],"When":[151],"volume":[154,318],"reached":[155],"approximately":[156],"200":[157],"mm3,":[158],"enrolled":[161,173],"study.":[164],"Tumor":[165,321],"size":[166],"was":[167,186,208,221,313,342],"measured":[168,376],"calipers":[170],"weekly":[171],"until":[172],"every":[175],"3":[176,230,263,341],"days":[177,213],"after":[178],"experiment":[179],"started.":[180],"In":[181,217],"vivo":[182,218],"determined":[187],"by":[188,223],"PET/CT":[190,225,373,384],"at":[192,250],"week":[194],"prior":[195],"initiation":[197],"confirmed":[201],"immunohistochemistry":[203,264],"staining.":[204],"(15":[206],"mg/kg)":[207],"administered":[209],"via":[210],"i.v.":[211],"on":[212,227],"0":[214,338],"3.":[216],"metabolism":[220],"quantified":[222],"[18F]-FDG":[224,310,332,383],"day":[228,251,337,340],"0,":[229],"6.":[232],"Mean,":[233],"standard":[234,241],"deviation,":[235],"sum,":[236],"frequency":[238],"histogram":[239],"uptake":[242],"value":[243],"(SUV)":[244],"quantified.":[246],"Tumors":[247],"harvested":[249],"6":[252],"histological":[254],"analysis.":[255,281],"Hematoxylin":[256],"eosin":[258],"(H&E)":[259],"cleaved":[261],"caspase":[262],"(IHC)":[265],"staining":[266],"determine":[270],"apoptosis.":[272],"Pearson\u2019s":[273],"correlation":[274],"ANOVA":[276],"as":[279],"statistical":[280],"Results:":[282],"SUVmean":[284],"(HER2+)":[287,292],"tumors":[288,293,303],"4.9\u00b11.5,":[290],"1.4\u00b10.2":[295],"(p<0.0001,":[296,306],"compared":[297,307],"BT474),":[299],"(HER2-)":[302],"1.1\u00b10.4":[305],"BT474).":[309],"SUV":[311,333,348],"sum":[312],"positively":[314,360,442],"(R2=0.1669,":[319],"p=0.0250).":[320],"volumes":[322],"showed":[323],"no":[324],"significant":[325],"normalized":[331],"concentration":[334,349],"from":[336],"negatively":[343],"baseline":[346],"[89Zr]-pertuzumab":[347,434],"(R2=0.3654,":[350],"p=0.05).":[351],"Conclusion:":[352],"Preliminary":[353],"results":[354],"show":[355],"paclitaxel":[356,438],"human":[367,448],"models.":[371],"quantitively":[375],"vivo,":[381],"revealed":[386],"early":[388],"signals":[389],"drug":[391],"efficacy.":[393],"discovery":[395],"will":[396],"help":[397],"identify":[398],"chemotherapy":[399],"responders":[400],"potentially":[402],"enhance":[403],"decision":[405],"making.":[406],"Acknowledgments:":[407],"We":[408],"thank":[409],"funding":[410],"sources":[411],"American":[412],"Cancer":[413,463,475],"Society":[414],"RSG-18-006-01-CCE":[415],"NIH":[417],"NCI":[418],"R01CA240589.":[419],"Citation":[420],"Format:":[421],"Yun":[422],"Lu,":[423],"Adriana":[424],"Massicano,":[425],"Patrick":[426],"Song,":[427],"Meng":[428],"Li,":[429],"Suzanne":[430],"Lapi,":[431],"Anna":[432],"Sorace.":[433],"pet":[435],"reveals":[437],"her2":[445],"xenograft":[451],"[abstract].":[454],"In:":[455],"Proceedings":[456],"2020":[459,466],"San":[460,469],"Antonio":[461],"Breast":[462],"Virtual":[464],"Symposium;":[465],"Dec":[467],"8-11;":[468],"Antonio,":[470],"TX.":[471],"Philadelphia":[472],"(PA):":[473],"AACR;":[474],"Res":[476],"2021;81(4":[477],"Suppl):Abstract":[478],"nr":[479],"PS3-03.":[480]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2021-03-01T00:00:00"}